Status:
COMPLETED
Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma
Lead Sponsor:
CHU de Reims
Conditions:
Carcinoma
Pancreatic Ductal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pancreatic adenocarcinoma represents more than 90% of pancreatic neoplasms. Around 14000 new cases of pancreatic adenocarcinoma are being diagnosed each year in France and about 8.6% in Grand Est regi...
Detailed Description
Unicentric prospective case control study comparing organochlorine levels including patients diagnosed with a pancreatic adenocarcinoma undergoing a surgery allowing to collect an adipose tissue sampl...
Eligibility Criteria
Inclusion
- inclusion criteria :
- Cases :
- patients diagnosed with a pancreatic adenocarcinoma, all stages allowed
- undergoing a surgery allowing to take a 10 grams adipose tissue sample
- Controls :
- patients without a pancreatic neoplasm on a 6 months old CT scan before inclusion
- undergoing a surgery allowing to take a 10 grams adipose tissue sample
- exclusion criteria :
- Cases :
- patients diagnosed with a pancreatic adenocarcinoma developed on IPMN or cystadenoma
- patient with a known genetic predisposition increasing pancreatic adenocarcinoma risk
- histopathology proof of a mixed neuroendocrine neoplasm
- no surgery allowing to take a 10 grams adipose tissue sample
- Controls :
- patients with a pancreatic neoplasm on a 6 months old CT scan before inclusion
- no surgery allowing to take a 10 grams adipose tissue sample
Exclusion
Key Trial Info
Start Date :
June 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04429490
Start Date
June 12 2020
End Date
May 15 2023
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France